Cargando…
Differential Response to Heart Rate Reduction by Carvedilol in Heart Failure and Reduced Ejection Fraction Between Sinus Rhythm and Atrial Fibrillation ― Insight From J-CHF Study ―
Background: Heart rate (HR) reduction by β-blocker might not benefit patients with heart failure and reduced ejection fraction (HFrEF) with atrial fibrillation (AF). Methods and Results: The J-CHF study was a prospective randomized multicenter trial that assigned 360 HFrEF patients to a 2.5 mg/5 mg/...
Autores principales: | Nagatomo, Yuji, Yoshikawa, Tsutomu, Okamoto, Hiroshi, Kitabatake, Akira, Hori, Masatsugu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Circulation Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922166/ https://www.ncbi.nlm.nih.gov/pubmed/33693221 http://dx.doi.org/10.1253/circrep.CR-20-0008 |
Ejemplares similares
-
Personalized Target Heart Rate for Patients with Heart Failure and Reduced Ejection Fraction
por: Yumita, Yusuke, et al.
Publicado: (2022) -
The mortality benefit of carvedilol versus bisoprolol in patients with heart failure with reduced ejection fraction
por: Choi, Ki Hong, et al.
Publicado: (2019) -
Biomarker profiles in heart failure with preserved vs. reduced ejection fraction: results from the DIAST‐CHF study
por: Eidizadeh, Abass, et al.
Publicado: (2022) -
Restoration of sinus rhythm by pulmonary vein isolation improves heart failure with preserved ejection fraction in atrial fibrillation patients
por: Rattka, Manuel, et al.
Publicado: (2020) -
Prognostic impact of left atrial function in heart failure with preserved ejection fraction in sinus rhythm vs. persistent atrial fibrillation
por: Schönbauer, Robert, et al.
Publicado: (2021)